InsidersTradesSigma
Cartesian Therapeutics, Inc. Stock: price and directors' dealings · United States · SEC (Form 4)
Track the Cartesian Therapeutics, Inc. stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). Market capitalisation: €253.6m. The latest transaction was reported on 9 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: SPRINGER TIMOTHY A. All data is free.
94
Insider Decl.
n/a
Thresholds
€2m
11 ops.
Buy Volume
€620,378
10 ops.
Sell Volume
41Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 9 June 2026
Declarations94 total
35,038 shares@ US$6.6421CommonSEC144:0001950047-26-005808
758,001 sharesCommon StockSEC:0002064832-26-000148:0
758,001 sharesCommon StockSEC:0002064832-26-000149:0
6,555 shares0Common StockSEC:0001453687-26-000066:0
23,766 shares@ US$6.819736.0% of flowCommon StockSEC:0001453687-26-000047:0
3,573 shares@ US$6.819714.5% of flowCommon StockSEC:0001453687-26-000046:0
10,591 shares@ US$6.819748.9% of flowCommon StockSEC:0001453687-26-000045:0
2,600 shares0Common StockSEC:0001453687-26-000039:0
143,200 shares0Common StockSEC:0001453687-26-000038:0
2,600 shares0Common StockSEC:0001453687-26-000037:0
27,000 shares0Common StockSEC:0001453687-26-000036:0
2,600 shares0Common StockSEC:0001453687-26-000035:0
6,500 shares0Common StockSEC:0001453687-26-000034:0
37,000 shares0Common StockSEC:0001453687-26-000033:0
2,600 shares0Common StockSEC:0001453687-26-000032:0
24,000 shares0Common StockSEC:0001453687-26-000031:0
2,600 shares0Common StockSEC:0001453687-26-000030:0
2,600 shares0Common StockSEC:0001453687-26-000029:0
2,600 shares0Common StockSEC:0001453687-26-000028:0
7,500 shares@ US$3.3016.8% of flowCommon StockSEC:0001453687-26-000002:0
5,800 shares0Common StockSEC:0001453687-25-000144:0
30,000 shares@ US$6.859966.9% of flowCommon StockSEC:0001453687-25-000132:0
Canonical exit: 4 Mar 2026 (T+90)
7,500 shares@ US$3.3020.4% of flowCommon StockSEC:0001453687-25-000130:0
20,000 shares0Common StockSEC:0001453687-25-000127:0
7,500 shares@ US$3.3026.9% of flowCommon StockSEC:0001453687-25-000089:0
25 of 94 declarations
About Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc. is a biopharmaceutical company focused on developing RNA-based therapies for serious diseases. It is listed on NASDAQ under the ticker XNAS.